Immunologist Paul Morgan is on a mission to find life-changing drugs. His lab at Cardiff University in Wales has been researching long COVID and its impact on patients for over two years. They have identified an immune system anomaly in some long haulers’ blood, which could be a potential target for treatment. While the research is still in its early stages, it holds promise for developing effective treatments for the disease. Other labs are also delving into the mysteries of long COVID, uncovering potential biomarkers and shedding light on the once-inscrutable disease. It’s an exciting time for long COVID research, with new discoveries emerging from the fog of uncertainty.
2024-03-04 09:00:00
Source from www.sciencenews.org